NL-OMON50931招募中4 期
Monitoring the effect of oral anticoagulants during cardiac catheterisation - POPular MEASURE trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patient must meet all of the following criteria:
- •- Male or female >= 18 years
- •- Undergoing non-emergent CAG or PCI
- •- Loaded with P2Y12 inhibitors before PCI
- •- Patients with signed informed consent
排除标准
- •Patients who fulfill the above mentioned inclusion criteria but who manifest
- •any of the following exclusion criteria will not be eligible for the study: -
- •Patients with hematologic, renal (estimated glomerular filtration <30
- •ml/min/1.73m2), hepatic (liver enzymes >2 times the upper limit of normal),
- •inflammatory (CRP >2 times the upper limit of normal) or neoplastic disorders -
- •Patients using nonsteroidal anti-inflammatory drugs, corticosteroids, or
- •hormone replacement therapy
研究者
相似试验
进行中（未招募）
1 期
Monitoring the effect of blood thinners during percutaneous coronary interventioAnticoagulation during percutaneous coronary interventionEUCTR2020-005298-29-NLSt. Antonius Hospital120
招募中
不适用
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
尚未招募
不适用
ew Oral Anticoagulants (NOAC) Study: Investigation of laboratory tests an development of a gold standard test for monitoring dabigatran and rivaroxaban therapyblood clotthrombosis1000752110014523NL-OMON39575Catharina-ziekenhuis120
进行中（未招募）
1 期
A study to demonstrate that a new antikoagulation therapy with apixaban is safe compared to another antikoagulation therapy with phenprocoumon in patients with chronic kidney disease and atrial fibrillation.End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment and Atrial FibrillationMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 23.1Level: LLTClassification code 10076412Term: Chronic kidney disease stage 5System Organ Class: 100000004857EUCTR2015-005503-84-DEKompetenznetz Vorhofflimmern e.V.108
招募中
2 期
Comparison of the effects of Rivaroxaban and Apixaban with Heparin and Enoxaparin in patients undergoing gynecological oncological surgery.IRCT20220211053991N1Iran University of Medical Sciences80